Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000276:Adjuvants, Immunologic; D000818:Animals; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006020:Glycopeptides / Q000494:pharmacology*; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000139:chemically induced; D008297:Male; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D009161:Mycobacterium / Q000032:analysis; D009171:Mycolic Acids / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000276:immunology; D012882:Skin Tests; D013154:Spleen / Q000276:immunology
D000276:Adjuvants, Immunologic; D006020:Glycopeptides; D009171:Mycolic Acids; C017548:mycoloyl-N-acetylmuramyl-alanylisoglutamine; D000119:Acetylmuramyl-Alanyl-Isoglutamine